| Application number | Title of the application | Filing Date | Status |
|---|
Array
(
[id] => 8151931
[patent_doc_number] => 08168414
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2012-05-01
[patent_title] => 'Beta-galactosidase with transgalactosylating activity'
[patent_app_type] => utility
[patent_app_number] => 12/225626
[patent_app_country] => US
[patent_app_date] => 2007-03-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 4
[patent_no_of_words] => 4346
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 20
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/08/168/08168414.pdf
[firstpage_image] =>[orig_patent_app_number] => 12225626
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/225626 | Beta-galactosidase with transgalactosylating activity | Mar 26, 2007 | Issued |
Array
(
[id] => 4845923
[patent_doc_number] => 20080182331
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-07-31
[patent_title] => 'Procedure for specific replacement of a copy of a gene present in the recipient genome by the integration of a gene different from that where the integration is made'
[patent_app_type] => utility
[patent_app_number] => 11/717037
[patent_app_country] => US
[patent_app_date] => 2007-03-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 13
[patent_no_of_words] => 9100
[patent_no_of_claims] => 79
[patent_no_of_ind_claims] => 11
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0182/20080182331.pdf
[firstpage_image] =>[orig_patent_app_number] => 11717037
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/717037 | Procedure for specific replacement of a copy of a gene present in the recipient genome by the integration of a gene different from that where the integration is made | Mar 12, 2007 | Abandoned |
Array
(
[id] => 5132686
[patent_doc_number] => 20070209083
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-09-06
[patent_title] => 'Cell and transgenic animal modelling human antigenic presentation and their uses'
[patent_app_type] => utility
[patent_app_number] => 11/709838
[patent_app_country] => US
[patent_app_date] => 2007-02-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11520
[patent_no_of_claims] => 37
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0209/20070209083.pdf
[firstpage_image] =>[orig_patent_app_number] => 11709838
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/709838 | Cell and transgenic animal modelling human antigenic presentation and their uses | Feb 22, 2007 | Abandoned |
Array
(
[id] => 5231471
[patent_doc_number] => 20070293579
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-12-20
[patent_title] => 'USE OF CARP INHIBITORS FOR THE TREATMENT OF HEART DISEASES'
[patent_app_type] => utility
[patent_app_number] => 11/676990
[patent_app_country] => US
[patent_app_date] => 2007-02-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4187
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 9
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0293/20070293579.pdf
[firstpage_image] =>[orig_patent_app_number] => 11676990
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/676990 | USE OF CARP INHIBITORS FOR THE TREATMENT OF HEART DISEASES | Feb 19, 2007 | Abandoned |
Array
(
[id] => 8114405
[patent_doc_number] => 08158422
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2012-04-17
[patent_title] => 'Erythroid cells producing adult-type β-hemoglobin generated from human embryonic stem cells'
[patent_app_type] => utility
[patent_app_number] => 11/672724
[patent_app_country] => US
[patent_app_date] => 2007-02-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 4267
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 138
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/08/158/08158422.pdf
[firstpage_image] =>[orig_patent_app_number] => 11672724
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/672724 | Erythroid cells producing adult-type β-hemoglobin generated from human embryonic stem cells | Feb 7, 2007 | Issued |
Array
(
[id] => 5367847
[patent_doc_number] => 20090305406
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-12-10
[patent_title] => 'Method of cultivation of human mesenchymal stem cells, particularly for the treatment of non-healing fractures, and bioreactor for carrying out this cultivation method'
[patent_app_type] => utility
[patent_app_number] => 12/162200
[patent_app_country] => US
[patent_app_date] => 2007-01-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 17
[patent_figures_cnt] => 17
[patent_no_of_words] => 16285
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0305/20090305406.pdf
[firstpage_image] =>[orig_patent_app_number] => 12162200
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/162200 | Method of cultivation of human mesenchymal stem cells, particularly for the treatment of non-healing fractures, and bioreactor for carrying out this cultivation method | Jan 22, 2007 | Abandoned |
Array
(
[id] => 6532337
[patent_doc_number] => 20100221339
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-09-02
[patent_title] => 'Use of a combination of morphine and at least one opiate antagonist to treat opiate dependency and prevent non-oral opiate abuse among opiate addicts'
[patent_app_type] => utility
[patent_app_number] => 12/161397
[patent_app_country] => US
[patent_app_date] => 2007-01-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3895
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0221/20100221339.pdf
[firstpage_image] =>[orig_patent_app_number] => 12161397
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/161397 | Use of a combination of morphine and at least one opiate antagonist to treat opiate dependency and prevent non-oral opiate abuse among opiate addicts | Jan 18, 2007 | Abandoned |
Array
(
[id] => 5552709
[patent_doc_number] => 20090286695
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-11-19
[patent_title] => 'LUMINESCENT STEM CELLS AND USES THEREOF'
[patent_app_type] => utility
[patent_app_number] => 12/160426
[patent_app_country] => US
[patent_app_date] => 2007-01-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 28
[patent_figures_cnt] => 28
[patent_no_of_words] => 15585
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 14
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0286/20090286695.pdf
[firstpage_image] =>[orig_patent_app_number] => 12160426
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/160426 | LUMINESCENT STEM CELLS AND USES THEREOF | Jan 9, 2007 | Abandoned |
Array
(
[id] => 5100806
[patent_doc_number] => 20070184068
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-08-09
[patent_title] => 'Immunostimulatory nucleic acid packaged particles for the treatment of hypersensitivity'
[patent_app_type] => utility
[patent_app_number] => 11/638664
[patent_app_country] => US
[patent_app_date] => 2006-12-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 54319
[patent_no_of_claims] => 79
[patent_no_of_ind_claims] => 13
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0184/20070184068.pdf
[firstpage_image] =>[orig_patent_app_number] => 11638664
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/638664 | Immunostimulatory nucleic acid packaged particles for the treatment of hypersensitivity | Dec 13, 2006 | Abandoned |
Array
(
[id] => 5173858
[patent_doc_number] => 20070074298
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-03-29
[patent_title] => 'Versican and epithelial-mesenchymal interaction'
[patent_app_type] => utility
[patent_app_number] => 11/636078
[patent_app_country] => US
[patent_app_date] => 2006-12-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 6581
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0074/20070074298.pdf
[firstpage_image] =>[orig_patent_app_number] => 11636078
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/636078 | Versican and epithelial-mesenchymal interaction | Dec 7, 2006 | Abandoned |
Array
(
[id] => 5391707
[patent_doc_number] => 20090209020
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-08-20
[patent_title] => 'collagenous matrix with improved porosity and tensile strength and preparation method therefore by using mechanical stimulation system'
[patent_app_type] => utility
[patent_app_number] => 12/084570
[patent_app_country] => US
[patent_app_date] => 2006-11-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 4553
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0209/20090209020.pdf
[firstpage_image] =>[orig_patent_app_number] => 12084570
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/084570 | collagenous matrix with improved porosity and tensile strength and preparation method therefore by using mechanical stimulation system | Nov 5, 2006 | Abandoned |
Array
(
[id] => 4726598
[patent_doc_number] => 20080206139
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-08-28
[patent_title] => 'DELIVERY SYSTEM FOR DIAGNOSTIC AND THERAPEUTIC AGENTS'
[patent_app_type] => utility
[patent_app_number] => 11/556574
[patent_app_country] => US
[patent_app_date] => 2006-11-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 16
[patent_no_of_words] => 18602
[patent_no_of_claims] => 65
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0206/20080206139.pdf
[firstpage_image] =>[orig_patent_app_number] => 11556574
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/556574 | DELIVERY SYSTEM FOR DIAGNOSTIC AND THERAPEUTIC AGENTS | Nov 2, 2006 | Abandoned |
| 10/569995 | Method of Selecting Animal Models from Animals Which Have Been Subject to Mutagenesis, and the Use of Myb Transcription Factors for Screening | Oct 11, 2006 | Abandoned |
Array
(
[id] => 4747648
[patent_doc_number] => 20080092250
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-04-17
[patent_title] => 'Activity-induced pain in animal model of osteoarthritis'
[patent_app_type] => utility
[patent_app_number] => 11/546714
[patent_app_country] => US
[patent_app_date] => 2006-10-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 3412
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0092/20080092250.pdf
[firstpage_image] =>[orig_patent_app_number] => 11546714
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/546714 | Activity-induced pain in animal model of osteoarthritis | Oct 11, 2006 | Abandoned |
Array
(
[id] => 5215608
[patent_doc_number] => 20070104689
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-05-10
[patent_title] => 'Compositions and methods for treating tumors presenting survivin antigens'
[patent_app_type] => utility
[patent_app_number] => 11/527195
[patent_app_country] => US
[patent_app_date] => 2006-09-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 15
[patent_no_of_words] => 23826
[patent_no_of_claims] => 52
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0104/20070104689.pdf
[firstpage_image] =>[orig_patent_app_number] => 11527195
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/527195 | Compositions and methods for treating tumors presenting survivin antigens | Sep 25, 2006 | Abandoned |
Array
(
[id] => 5360493
[patent_doc_number] => 20090035287
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-02-05
[patent_title] => 'ATRIAL NATRIURETIC PEPTIDE (ANP) SPLICE VARIANTS AND METHODS OF USING SAME'
[patent_app_type] => utility
[patent_app_number] => 12/088132
[patent_app_country] => US
[patent_app_date] => 2006-09-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 22
[patent_figures_cnt] => 22
[patent_no_of_words] => 32865
[patent_no_of_claims] => 39
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0035/20090035287.pdf
[firstpage_image] =>[orig_patent_app_number] => 12088132
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/088132 | ATRIAL NATRIURETIC PEPTIDE (ANP) SPLICE VARIANTS AND METHODS OF USING SAME | Sep 25, 2006 | Abandoned |
Array
(
[id] => 5107046
[patent_doc_number] => 20070065924
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-03-22
[patent_title] => 'Isolated polynucleotide sequence with IRES activity'
[patent_app_type] => utility
[patent_app_number] => 11/524428
[patent_app_country] => US
[patent_app_date] => 2006-09-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 7962
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0065/20070065924.pdf
[firstpage_image] =>[orig_patent_app_number] => 11524428
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/524428 | Isolated polynucleotide sequence with IRES activity | Sep 19, 2006 | Abandoned |
Array
(
[id] => 5056908
[patent_doc_number] => 20070059830
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-03-15
[patent_title] => 'Method for creating myeloid cell lines'
[patent_app_type] => utility
[patent_app_number] => 11/509314
[patent_app_country] => US
[patent_app_date] => 2006-08-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 14540
[patent_no_of_claims] => 39
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0059/20070059830.pdf
[firstpage_image] =>[orig_patent_app_number] => 11509314
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/509314 | Method for creating myeloid cell lines | Aug 23, 2006 | Abandoned |
Array
(
[id] => 4792680
[patent_doc_number] => 20080293654
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-11-27
[patent_title] => 'Therapeutic methods using Smads'
[patent_app_type] => utility
[patent_app_number] => 11/499750
[patent_app_country] => US
[patent_app_date] => 2006-08-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 17446
[patent_no_of_claims] => 49
[patent_no_of_ind_claims] => 18
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0293/20080293654.pdf
[firstpage_image] =>[orig_patent_app_number] => 11499750
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/499750 | Therapeutic methods using Smads | Aug 2, 2006 | Abandoned |
Array
(
[id] => 5074793
[patent_doc_number] => 20070014768
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-01-18
[patent_title] => 'Combined tumor suppressor gene therapy and chemotherapy in the treatment of neoplasms'
[patent_app_type] => utility
[patent_app_number] => 11/493429
[patent_app_country] => US
[patent_app_date] => 2006-07-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 13
[patent_no_of_words] => 33300
[patent_no_of_claims] => 32
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0014/20070014768.pdf
[firstpage_image] =>[orig_patent_app_number] => 11493429
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/493429 | Combined tumor suppressor gene therapy and chemotherapy in the treatment of neoplasms | Jul 24, 2006 | Abandoned |